Expert Talks With Kalkine || Ms Jennifer Chow, Chief Operating Officer of Chimeric Therapeutics

Welcome you all to “Executive corner - Expert talks- 20 mins Round up with Ms Jennifer Chow - Chief Operating Officer of Chimeric Therapeutics.” 

Chimeric Therapeutics is an ASX listed company developing ground-breaking CAR T cell therapies for solid tumors based on research at the City of Hope Cancer Centre in Los Angeles. The technology known as CLTX-CAR T, uses chlorotoxin, a peptide discovered in scorpion venom, as the tumor targeting component of the CAR to reprogram T cells and is currently undergoing Phase 1 clinical trials at City of Hope in glioblastoma.

Comment


Disclaimer

Ad

GET A FREE STOCK REPORT


Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.


   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK